477 related articles for article (PubMed ID: 25560793)
1. One-stage vs. chromogenic assays in haemophilia A.
Potgieter JJ; Damgaard M; Hillarp A
Eur J Haematol; 2015 Feb; 94 Suppl 77():38-44. PubMed ID: 25560793
[TBL] [Abstract][Full Text] [Related]
2. Assay discrepancy in mild haemophilia A.
Armstrong E; Hillarp A
Eur J Haematol Suppl; 2014 Aug; 76():48-50. PubMed ID: 24957107
[TBL] [Abstract][Full Text] [Related]
3. Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays.
Pavlova A; Delev D; Pezeshkpoor B; Müller J; Oldenburg J
Thromb Haemost; 2014 May; 111(5):851-61. PubMed ID: 24452774
[TBL] [Abstract][Full Text] [Related]
4. One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype.
Cid AR; Calabuig M; Cortina V; Casaña P; Haya S; Moret A; Cabrera N; Aznar JA
Haemophilia; 2008 Sep; 14(5):1049-54. PubMed ID: 18540892
[TBL] [Abstract][Full Text] [Related]
5. Assay discrepancy in mild haemophilia A: entire population study in a National Haemophilia Centre.
Poulsen AL; Pedersen LH; Hvas AM; Poulsen LH; Thykjaer H; Ingerslev J
Haemophilia; 2009 Jan; 15(1):285-9. PubMed ID: 19149854
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic testing for mild hemophilia a in patients with discrepant one-stage, two-stage, and chromogenic factor VIII:C assays.
Duncan EM; Rodgers SE; McRae SJ
Semin Thromb Hemost; 2013 Apr; 39(3):272-82. PubMed ID: 23460037
[TBL] [Abstract][Full Text] [Related]
7. Chromogenic Factor VIII Assays for Improved Diagnosis of Hemophilia A.
Rodgers S; Duncan E
Methods Mol Biol; 2017; 1646():265-276. PubMed ID: 28804835
[TBL] [Abstract][Full Text] [Related]
8. Performance of recalibrated ReFacto laboratory standard in the measurement of FVIII plasma concentration via the chromogenic and one-stage assays after infusion of recalibrated ReFacto (B-domain deleted recombinant factor VIII).
Santoro C; Iorio A; Ferrante F; Pallotta A; Pignoloni P; Biondo F; Agnelli G; Mazzucconi MG
Haemophilia; 2009 May; 15(3):779-87. PubMed ID: 19298379
[TBL] [Abstract][Full Text] [Related]
9. Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy.
Gilmore R; Harmon S; Gannon C; Byrne M; O'Donnell JS; Jenkins PV
Haemophilia; 2010 Jul; 16(4):671-4. PubMed ID: 20148980
[TBL] [Abstract][Full Text] [Related]
10. Validation of a procedure for potency assessing of a high purity factor VIII concentrate--comparison of different factor VIII coagulant assays and effect of prediluent.
Mazurier C; Parquet-Gernez A; Goudemand M
Thromb Haemost; 1990 Oct; 64(2):251-5. PubMed ID: 2125374
[TBL] [Abstract][Full Text] [Related]
11. Performance evaluation of Revohem
Suzuki A; Suzuki N; Kanematsu T; Shinohara S; Arai N; Kikuchi R; Matsushita T
Int J Lab Hematol; 2019 Oct; 41(5):664-670. PubMed ID: 31271527
[TBL] [Abstract][Full Text] [Related]
12. In vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one-stage and two-stage factor VIII assay results.
Rodgers SE; Duncan EM; Barbulescu DM; Quinn DM; Lloyd JV
Br J Haematol; 2007 Jan; 136(1):138-45. PubMed ID: 17222201
[TBL] [Abstract][Full Text] [Related]
13. Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B.
Kihlberg K; Strandberg K; Rosén S; Ljung R; Astermark J
Haemophilia; 2017 Jul; 23(4):620-627. PubMed ID: 28440032
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility and impact of the use of the chromogenic vs one-stage factor activity assays in haemophilia A and B.
Marlar RA; Strandberg K; Shima M; Adcock DM
Eur J Haematol; 2020 Jan; 104(1):3-14. PubMed ID: 31606899
[TBL] [Abstract][Full Text] [Related]
15. In silico and in vitro evaluation of the impact of mutations in non-severe haemophilia A patients on assay discrepancies.
Pezeshkpoor B; Gazorpak M; Berkemeier AC; Singer H; Pavlova A; Biswas A; Oldenburg J
Ann Hematol; 2019 Aug; 98(8):1855-1865. PubMed ID: 30997536
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of three automated chromogenic FVIII kits for the diagnosis of mild discrepant haemophilia A.
Rodgers SE; Duncan EM; Sobieraj-Teague M; Lloyd JV
Int J Lab Hematol; 2009 Apr; 31(2):180-8. PubMed ID: 18190586
[TBL] [Abstract][Full Text] [Related]
17. Factor VIII assay variability in postinfusion samples containing full length and B-domain deleted FVIII.
Kitchen S; Jennings I; Makris M; Kitchen DP; Woods TA; Walker ID
Haemophilia; 2016 Sep; 22(5):806-12. PubMed ID: 27217329
[TBL] [Abstract][Full Text] [Related]
18. A multicenter pharmacokinetic study of the B-domain deleted recombinant factor VIII concentrate using different assays and standards.
Morfini M; Cinotti S; Bellatreccia A; Paladino E; Gringeri A; Mannucci PM;
J Thromb Haemost; 2003 Nov; 1(11):2283-9. PubMed ID: 14629459
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements.
Trossaert M; Lienhart A; Nougier C; Fretigny M; Sigaud M; Meunier S; Fouassier M; Ternisien C; Negrier C; Dargaud Y
Haemophilia; 2014 Jul; 20(4):550-8. PubMed ID: 24517184
[TBL] [Abstract][Full Text] [Related]
20. Factor VIII assay mimicking in vivo coagulation conditions.
Kusch M; Grundmann C; Keitel S; König H
Haemophilia; 2014 Mar; 20(2):e164-70. PubMed ID: 24286249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
